Suppr超能文献

新型利尿β受体阻滞剂替诺洛尔对大鼠尿前列腺素排泄的影响。

Effect of tienoxolol, a new diuretic beta-blocking agent, on urinary prostaglandin excretion in the rat.

作者信息

Caussade F, Cloarec A

机构信息

Laboratoires UPSA, Rueil-Malmaison, France.

出版信息

Br J Pharmacol. 1993 May;109(1):278-84. doi: 10.1111/j.1476-5381.1993.tb13565.x.

Abstract
  1. The effects of tienoxolol, (ethyl 2-[3-[(1,1-dimethylethyl)amino]-2-hydroxypropoxy]-5- [(2-thienylcarbonyl) amino] benzoate, hydrochloride), a novel drug exhibiting both diuretic and beta-adrenoceptor blocking properties, were investigated on urinary 6-keto-prostaglandin F1 alpha (6-keto-PGF1 alpha) and PGE2 excretion in the rat and compared to those of reference diuretic (furosemide) and beta-adrenoceptor antagonists (acebutolol, propranolol). Since tienoxolol was shown to bind to A1 and A2 adenosine receptors, the action of theophylline was also evaluated. 2. Tienoxolol (8-128 mg kg-1, p.o.) induced a dose-related increase of 6-keto-PGF1 alpha excretion from 32 mg kg-1 but a significant elevation of urinary PGE2 levels was only reached after administration of 128 mg kg-1. However, renal prostaglandin concentrations were not modified by tienoxolol. 3. Furosemide (32 mg kg-1) displayed a strong diuretic activity but did not enhance 6-keto-PGF1 alpha excretion. Likewise, the latter was unaffected by acebutolol and propranolol (128 mg kg-1) and no significant diuresis was observed following administration of these two beta-blocking agents. Theophylline (64 mg kg-1), like tienoxolol, was able to induce both diuresis and urinary prostaglandin excretion. Furthermore, they bound with similar affinities to A1 and A2 adenosine receptors. This led to the suggestion that a relationship between P1-purinoceptors, prostaglandin release, diuresis and natriuresis could exist. 4. Oral co-administration of NECA (0.2 mg kg-1) with tienoxolol markedly reduced the urinary 6-keto-PGF1 alpha excretion observed when tienoxolol was administered alone. However, neither diuresis nor natriuresis were modified, demonstrating that the proposed relationship was untenable. 5. In conclusion, PGI2 probably does not participate in the diuretic and natriuretic activity oftienoxolol. The increase of urinary 6-keto-PGF1alpha excretion may result not only from the haemodynamic properties of the drug but also from the rise of the urinary flow induced by tienoxolol.
摘要
  1. 对一种兼具利尿和β-肾上腺素受体阻断特性的新型药物替诺洛尔(2-[3-[(1,1-二甲基乙基)氨基]-2-羟基丙氧基]-5-[(2-噻吩基羰基)氨基]苯甲酸乙酯盐酸盐)对大鼠尿中6-酮-前列腺素F1α(6-keto-PGF1α)和PGE2排泄的影响进行了研究,并与参考利尿剂(呋塞米)和β-肾上腺素受体拮抗剂(醋丁洛尔、普萘洛尔)的影响进行了比较。由于已证明替诺洛尔可与A1和A2腺苷受体结合,因此也评估了茶碱的作用。2. 替诺洛尔(8 - 128 mg kg-1,口服)从32 mg kg-1起引起6-keto-PGF1α排泄呈剂量相关增加,但仅在给予128 mg kg-1后尿中PGE2水平才显著升高。然而,替诺洛尔未改变肾前列腺素浓度。3. 呋塞米(32 mg kg-1)显示出强烈的利尿活性,但未增强6-keto-PGF1α排泄。同样,后者不受醋丁洛尔和普萘洛尔(128 mg kg-1)影响,给予这两种β受体阻滞剂后未观察到明显利尿作用。茶碱(64 mg kg-1)与替诺洛尔一样,能够诱导利尿和尿前列腺素排泄。此外,它们与A1和A2腺苷受体的结合亲和力相似。这表明P1-嘌呤受体、前列腺素释放、利尿和利钠之间可能存在关系。4. NECA(0.2 mg kg-1)与替诺洛尔口服联合给药显著降低了单独给予替诺洛尔时观察到的尿6-keto-PGF1α排泄。然而,利尿和利钠均未改变,表明所提出的关系不成立。5. 总之,PGI2可能不参与替诺洛尔的利尿和利钠活性。尿中6-keto-PGF1α排泄增加可能不仅源于药物的血流动力学特性,还源于替诺洛尔引起的尿流量增加。

相似文献

4
The interaction of paracetamol with frusemide.对乙酰氨基酚与呋塞米的相互作用。
Br J Clin Pharmacol. 1994 May;37(5):464-7. doi: 10.1111/j.1365-2125.1994.tb05716.x.

本文引用的文献

1
Effects of methylxanthines on urinary prostaglandin E excretion in rats.
Jpn J Pharmacol. 1981 Apr;31(2):253-9. doi: 10.1254/jjp.31.253.
4
Prostacyclin has effects on proximal and distal tubular function in the dog.
Prostaglandins Med. 1980 Mar;4(3):141-6. doi: 10.1016/0161-4630(80)90075-0.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验